bioPulse
Biotech investment insights for retail traders
bioPulse launched on March 11, 2025 with 9 votes, #3,084 of 7,215 launches that month and more than 50% of that year's launches.
What it does
bioPulse makes complex clinical trial data digestible with AI-powered summaries and insights for retail biotech investors. Join the beta waitlist.
Does a similar job
all alternatives →
DataPulse Open Beta2023 · datapulse.app · ▲142Simple, real-time, fun & lightweight web analytics solution
MacroPulse2025 · macropulse.co · ▲20Hi HN, my friend Ivan and I are retail investors and consume financial news regularly. We both think the current finance news is unwatchable, filled with exaggerated titles, writer bias and anecdotal details, so we built MacroPulse to make the financial news app we want. MacroPulse aggregates financial news, and the AI creates a single concise summary with key points for every stock daily. If you want to know the details, you can click the key points, the AI will give you extensive details. With the new format, I hope we can save you time while making you learn more about the details.…
BioTradingArena – Benchmark for LLMs to predict biotech stock movementsFeb 2026 · biotradingarena.com · ▲35Hi HN, My friend and I have been experimenting with using LLMs to reason about biotech stocks. Unlike many other sectors, Biotech trading is largely event-driven: FDA decisions, clinical trial readouts, safety updates, or changes in trial design can cause a stock to 3x in a single day (https://www.biotradingarena.com/cases/MDGL_2023-12-14_Resmet...). Interpreting these ‘catalysts,’ which comes in the form of a press release, usually requires analysts with previous expertise in biology or medicine. A catalyst that sounds “positive” can still lead to a selloff if, for…
Source: Product Hunt launch ↗
Launched alongside, March 2025
the whole month →
Mimic Human Research & Save Findings in AI Knowledge Base
AI · 2025 · sider.ai
